Tailored immune solutions to suit your patients
13th May, 2022

This post is specifically for health practitioners. Create a free account

Alternatively, view general public info.

Learn more about vital.ly

 

Maintaining a robust immune system is a fine-tuned process, striking a balance between stimulatory and regulatory immune functions; defending against infection, responding to tissue injury and repair, and regulating cellular changes that can lead to disease. Environmental factors, including poor gut health, nutritional deficiencies, sleep dysregulation, and stress may disrupt this balance, causing a reduced or dysfunctional immune response. 

In susceptible individuals, these factors drive pathological processes that exhaust the immune response (increasing susceptibility to an acute infectious onset and paving the way for recurrent and chronic infection), increase immune reactivity (creating allergens from otherwise innocuous substances), or deteriorate immune tolerance and inflammatory control mechanisms (leading to autoreactivity and inflammation). The complexity of immune presentations therefore requires evidence-based solutions that target insufficient immune stimulation (associated with infection), as well as aberrant immune overactivity (associated with allergy and autoimmunity).

 

Bringing Immune Balance to Your Patients

Fortunately, Metagenics provide tailored immune solutions (Figure 1), enabling symptomatic relief while also building immune resilience. This approach utilises a suite of herbal and nutritional interventions that provide immune stimulation for acute, recurrent and chronic infections, as well as anti-inflammatory support and immune regulation for allergic and autoimmune conditions. Key nutrients, which are foundational to immune balance, are also available to prevent an infectious onset and restore balance to a dysfunctional immune response.

 

Figure 1. Condition-specific solutions that enhance immunity and prevent immune dysfunction

Figure 1 

 

When Pathogens Attack

For patients susceptible to infection, strain-specific probiotics with proven human health benefits, such as those in Lactobacillus plantarum HEAL9, Lactobacillus paracasei 8700:2 and Lactobacillus rhamnosus (LGG®) to Boost Immunity, are uniquely positioned to enhance the immune response.

Illustrating this, a clinical trial involving 898 participants who were administered 500 million colony-forming units (CFU)/d each of HEAL 9 and 8700:2 for 12 weeks revealed a 30% reduction in the incidence of recurring colds and an 18% decline in analgesic use compared to placebo (1). Additionally, a meta-analysis consisting of 1,805 children aged 0 to 18 years demonstrated that Lactobacillus rhamnosus (LGG®) significantly reduced acute otitis media episodes, upper respiratory tract infections and antibiotic treatments, while also decreasing overall respiratory infections in children older than 1 year (2).

 

Amplifying Immunity During Acute Infections

Combining immune-stimulating probiotics with herbs that have been demonstrated to boost immune function may alleviate acute infections such as cold and flu. For instance, a meta-analysis of 33 randomised controlled trials consisting of 7,175 patients revealed andrographis, (supplemented in doses ranging between 15.75 mg/d to 1,200 mg/d) significantly reduced cold and influenza symptoms and shortened illness by one to three days (3). Recent research has shown epigallocatechin-gallate (EGCG) from Camellia sinensis (green tea) forms ionophores with zinc to increase intracellular zinc concentrations (4) and inhibit replication of ribonucleic acid (RNA) viruses including rhinoviruses, influenza and coronaviruses (5). Additionally, ingredients such as vitamins C (6) and D (7) may also help to modulate immune function, regulate inflammatory cytokine activity and reduce viral load, minimising the severity of acute respiratory tract infections. The combination of these ingredients, found in NK Cell Regulation, are therefore indicated for patients that require acute infectious management. 

 

Mushrooms for Managing Recurrent Infections

For recurrent infections, ingredients within Cordyceps, Coriolus and Reishi for Immune Stimulation have been found to increase resistance to infectious illness (8,9,10,11). Specifically, the β-glucan structure present within mushroom polysaccharides stimulate T cell immunity, supporting adaptive immunity when fighting infection (12).

Highlighting these benefits, a study involving participants with positive antibody titres for Epstein-Barr virus demonstrated a 77% increase in T cell activation and a 35% increase in natural killer (NK) cell activity when administered 3 g/d of coriolus for two months (Figure 2) (13). Additionally, 350 mg/d of reishi beta-glucans ingested for five days per week over 12 weeks was found to increase cluster of differentiation 4 (CD4+) and CD8+ T cell lymphocytes (14). As such, Cordyceps, Coriolus and Reishi for Immune Stimulation is an appropriate consideration to mitigate recurrent infections.

 

Figure 2. Increased T cell activation and NK cell activity associated with coriolus supplementation (13)

Figure 2 

 

Additionally, Mushrooms and Astragalus for Immune System Support combines coriolus and reishi with herb, Astragalus membranaceous (astragalus), for patients requiring immune support and fatigue management (15). Astragalus has been demonstrated to modulate the inflammatory response, while also increasing leukocyte populations, antigen presentation and complement protein synthesis (15). Known as a ‘Qi-tonifying’ herb, astragalus has a long history of use in Traditional Chinese Medicine for reducing fatigue and improving vitality in patients with a debilitating illness (16,17) providing an alternative for individuals experiencing fatigue associated with recurrent infection.

 

Active Hexose Correlated Compound (AHCC™) to Resolve Chronic Infections

For chronic or serious infection, where the immune system is unable to eradicate the pathogen, a propriety enzyme-fermented extract of shiitake, known as AHCC™, has been found to stimulate innate and adaptive immune responses. These actions include boosting cytokine production, enhancing NK cell function, promoting macrophage activity, and increasing dendritic cell numbers (18,19,20,21).

A testament to these benefits, AHCC™ has been used clinically in more than 600 international hospitals (22,23)  and had been shown to heighten immune response in over 20 human clinical trials (19).

Recently, supplementation with AHCC™ at 3 g/d for three to six months increased the clearance of chronic cervical human papillomavirus infection in 66% of participants (24). Additionally, AHCC™ provided to cancer patients receiving chemotherapy inhibited human herpes virus-6 reactivation (25). Therefore, AHCC™ and Ginger is suitable for immunosuppressed individuals, particularly those with chronic infections.  

 

Regulating Overactive Immunity

Patients presenting with immune hypersensitiveness, such as allergies, atopic conditions, and autoimmunity, may benefit from Lactobacillus paracasei LP-33® and Lactobacillus rhamnosus LGG® for Immune Control. These immune-modulating, anti-inflammatory probiotic strains promote immune regulation by interacting with dendritic cells within the gut-associated lymphoid tissue, stimulating the production of regulatory T cells and regulatory cytokines, such as interleukin-10 (IL-10) and transforming growth-factor beta (TGF-β) (26). Demonstrating LP-33™’s effectiveness, subjects with allergic rhinitis experienced significant improvements in their Rhinitis Quality Of Life (RQLQ) score, nasal and ocular symptoms after five weeks of supplementation (27). Further, LGG® has been shown to significantly reduce rheumatoid arthritis (RA) inflammation (28), decrease Crohn’s disease activity (29) and help maintain clinical remission alongside mesalazine in ulcerative colitis patients (30).

 

Dialling Down the Allergic Response

For patients presenting with food and environmental allergies, treatment alternatives that support immune regulation and promote immune tolerance to allergens can allow patients to live more expansive lives. For instance, reishi has been found to restore the T helper 1 (Th1)/Th2 imbalance and histamine-induced immune response associated with allergy (31,32). Further, perilla’s anti-allergic activities have been highlighted in several clinical trials, demonstrating reduced Th2 cytokine production, inhibition of nuclear factor kappa B (NFƙB) and subsequent cytokine synthesis, as well as minimising tumour necrosis factor-alpha (TNF-α), immunoglobulin E (IgE) antibodies and histamine release (33).

Comprised of these ingredients, Chinese Mushrooms, Skullcap and Perilla for Allergy Tolerance helps to moderate the underlying factors that perpetuate allergy (Figure 3). These include promoting Th cell regulation, modulating gastrointestinal and systemic immunity, regulating inflammation, and supporting liver clearance of immune complexes, which collectively enhance allergen tolerance and reduce allergic reactions.

 

Figure 3. Key ingredients to build tolerance

Figure 3 

While the treatment of allergic drivers is underway, Quercetin, Bromelain and Aller-7® for Allergy Symptom Relief can alleviate symptomatic discomfort by minimising the local and systemic inflammation associated with allergy. Clinically trialled Aller-7® (tested in over 500 patients) (34,35) along with quercetin and bromelains, can reduce allergic reactions through potent inhibition of histamine release and reduction of oedema and inflammatory processes (36,37,38,39,40). As such, this combination provides relief of symptoms in those suffering from a variety of allergies and sensitivities including respiratory, skin and food reactions.

 

Attenuating Autoimmune Inflammation and Encouraging Resolution

For patients presenting with autoimmunity or conditions involving increased inflammatory load, formulas that attenuate inflammation, mitigate tissue damage and promote resolution can help to repair damage to afflicted tissues and reduce disease activity. Specifically, BCM-95™ Turmeric and Devil’s Claw to Treat Chronic Inflammation contains several herbs that reduce the production of inflammatory mediators.

BCM-95™ Turmeric has been shown to inhibit the activity of the inflammatory gene, cyclooxygenase–2 (41),  as well as a plethora of other pro-inflammatory compounds (42). Additionally, both BCM-95™ Turmeric and BosPure® Boswellia have been found to prevent the activation of NFƙB, therefore inhibiting signalling pathways involved in down-stream inflammatory cytokine production (43,44). For added benefit, devil’s claw provides analgesic effects by simultaneously increasing gamma-aminobutyric acid (GABA) activity and reducing glutamate signalling (45), while Jamaica dogwood has been shown to inhibit inflammatory enzymes associated with pain (46). In doing so, these herbs may reduce pain sensations associated with chronic inflammation.

In instances of chronic, unresolved inflammation, where resolution rather than inhibition of inflammatory mediators is required, Specialised Pro-Resolving Mediators (SPMs) are recommended, particularly in patients with chronic inflammation or when medical conditions are exacerbated by inflammation. SPMs are lipid mediators that activate the resolution phase at the site of inflammation by regulating macrophage polarisation (switching from the M1 to the M2 phenotype), while also repairing tissue damage, enhancing pathogen clearance and preventing further pathological inflammation without immunosuppression (47,48).

 

Prevention is Always Better Than Cure

Foundational nutritional therapy using key ingredients such as zinc, vitamin C and vitamin D provides the key building blocks for immune health, paramount to maintaining a resilient immune response.

Zinc is integral to intracellular signalling pathways for both innate and adaptive immunity (49), along with the development of non-specific immunity, including neutrophils and NK cells, and acquired immunity (50). Research has found low zinc status correlates with increased susceptibility to infections, including diarrheal diseases or viral infections, as well as reduced T and B lymphocyte function, and decreased thymic hormone production (which regulates the development of immune-competent cells) (51).

Zinc combined with vitamin C has been found to alleviate common cold symptoms more effectively than placebo (52); a finding likely owing to vitamin C’s capacity to boost lymphocyte differentiation and proliferation, antibody synthesis and white blood cell production and function (53). As such, High Bioavailability Zinc with Vitamin C or High Bioavailability Zinc with P5P, are appropriate considerations for nourishing immune health.

Vitamin D also regulates immune function, with deficiency impacting the activity of T regulatory cells (54,55), as well as the production of antibodies and dendritic cell function (56). Further, vitamin D has been found to enhance the differentiation of monocytes to macrophages and stimulate white blood cell proliferation, essential to neutralising viral infections (57); placing vitamin D in good stead to boost immunity.

 

Immune Solutions Your Patients Will Love

Given the broad spectrum of immune presentations that can range anywhere from insufficient immune stimulation to heightened immune overactivity, a one-size-fits-all approach is far from ideal when treating immunological conditions. As such, evidence-based strategies to either regulate or stimulate the immune system, combined with preventative nutrition, allows Practitioners to prescribe customisable solutions with confidence, providing symptomatic relief while building a robust immune system that benefits your patients.

Loading...
References
1Ahrén IL, Hillman M, Nordström EA, Larsson N, Niskanen TM. Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomized, placebo-controlled clinical trial. J Nutr. 2021 Jan 4;151(1):214-222. doi: 10.1093/jn/nxaa353.
2Liu S, Hu P, Du X, Zhou T, Pei X. Lactobacillus rhamnosus GG supplementation for preventing respiratory infections in children: a meta-analysis of randomized, placebo-controlled trials. Indian Pediatr. 2013 Apr;50(4):377-81. doi: 10.1007/s13312-013-0123-z.
3Hu XY, Wu RH, Logue M, Blondel C, Lai LYW, Stuart B, et al. Andrographis paniculata (Chuān Xīn Lián) for symptomatic relief of acute respiratory tract infections in adults and children: a systematic review and meta-analysis. PLoS One. 2017 Aug 4;12(8):e0181780. doi: 10.1371/journal.pone.0181780.
4Dabbagh-Bazarbachi H, Clergeaud G, Quesada IM, Ortiz M, O'Sullivan CK, Fernández-Larrea JB. Zinc ionophore activity of quercetin and epigallocatechin-gallate: from Hepa 1-6 cells to a liposome model. J Agric Food Chem. 2014 Aug 13;62(32):8085-93. doi: 10.1021/jf5014633.
5Hoang BX, Han B. A possible application of hinokitiol as a natural zinc ionophore and anti-infective agent for the prevention and treatment of COVID-19 and viral infections. Med Hypotheses. 2020 Dec;145:110333. doi: 10.1016/j.mehy.2020.110333.
6Carr AC, Maggini S. Vitamin C and immune function. Nutrients. 2017 Nov 3;9(11):1211. doi: 10.3390/nu9111211.
7Jolliffe DA, Griffiths CJ, Martineau AR. Vitamin D in the prevention of acute respiratory infection: systematic review of clinical studies. J Steroid Biochem Mol Biol. 2013 Jul;136:321-9. doi: 10.1016/j.jsbmb.2012.11.017.
8Standish LJ, Wenner CA, Sweet ES, Bridge C, Nelson A, Martzen M, et al. Trametes versicolor mushroom immune therapy in breast cancer. J Soc Integr Oncol. 2008 Summer;6(3):122-8. PMID: 19087769.
9Yoshida H, Suzuki M, Sakaguchi R, Tani I, Kotani H, Shudo N, et al. Preferential induction of Th17 cells in vitro and in vivo by Fucogalactan from Ganoderma lucidum (Reishi). Biochem Biophys Res Commun. 2012;22(11):421-28. doi: 10.1016/j.bbrc.2012.04.135.
10Lakhanpal TN, Rana M. Medicinal and nutraceutical genetic resources of mushrooms. Plant Gen Res. 2005; 3(2); 288-303. doi: 10.1079/PGR200581.
11Zhou X, Luo L, Dressel W, Shadier G, Krumbiegel D, Schmidtke P, et al. Cordycepin is an immunoregulatory active ingredient of Cordyceps sinensis. Am J Chin Med. 2008;36(5):967-80. doi: 10.1142/S0192415X08006387.
12Mallet JF, Graham É, Ritz BW, Homma K, Matar C. Active hexose correlated compound (AHCC) promotes an intestinal immune response in BALB/c mice and in primary intestinal epithelial cell culture involving toll-like receptors TLR-2 and TLR-4. Eur J Nutr. 2016 Feb;55(1):139-46. doi: 10.1007/s00394-015-0832-2.
13Munroe JE. Chronic fatigue immune dysfunction syndrome. J Integrative Medicine. 2004;8:101-8.
14Henao SLD, Urrego SA, Cano AM, Higuita EA. randomized clinical trial for the evaluation of immune modulation by yogurt enriched with β-glucans from lingzhi or reishi medicinal mushroom, ganoderma lucidum (agaricomycetes), in children from Medellin, Colombia. Int J Med Mushrooms. 2018;20(8):705-716. doi: 10.1615/IntJMedMushrooms.2018026986.
15Jin M, Zhao K, Huang Q, Shang P. Structural features and biological activities of the polysaccharides from Astragalus membranaceus. Int J Biol Macromol. 2014 Mar;64:257-66. doi: 10.1016/j.ijbiomac.2013.12.002.
16Xu L, Xu XY, Hou XQ, Wang FG, Gao S, Zhang HT. Adjuvant therapy with Astragalus membranaceus for post-stroke fatigue: a systematic review. Metab Brain Dis. 2020 Jan;35(1):83-93. doi: 10.1007/s11011-019-00483-4.
17Yeh TS, Chuang HL, Huang WC, Chen YM, Huang CC, Hsu MC. Astragalus membranaceus improves exercise performance and ameliorates exercise-induced fatigue in trained mice. Molecules. 2014 Mar 3;19(3):2793-807. doi: 10.3390/molecules19032793.
18Cowawintaweewat S, Manoromana S, Sriplung H, Khuhaprema T, Tongtawe P, Tapchaisri P, et al. Prognostic improvement of patients with advanced liver cancer after active hexose correlated compound (AHCC) treatment. Asian Pac J Allergy Immunol. 2006 Mar;24(1):33-45. PMID: 16913187.
19Terakawa N, Matsui Y, Satoi S, Yanagimoto H, Takahashi K, Yamamoto T, et al. Immunological effect of active hexose correlated compound (AHCC) in healthy volunteers: a double-blind, placebo-controlled trial. Nutr Cancer. 2008;60(5):643-51. doi: 10.1080/01635580801993280.
20Yin Z, Fujii H, Walshe T. Effects of active hexose correlated compound on frequency of CD4+ and CD8+ T cells producing interferon-γ and/or tumour necrosis factor-α in healthy adults. Hum Immunol. 2010 Dec;71(12):1187-90. doi: 10.1016/j.humimm.2010.08.006.
21Takahashi T, Shinobu K, Nakayam K, Yamada M, Takeshita K, Yamada K, et al. Augmentation of canine cellular immune response by administration of AHCC [general lecture]. Presented at the 8th International Congress on Nutrition and Integrative Medicine (ICNIM) 2000.
22NutraNews Science, Nutrition, Prevention and Health. AHCC, a powerful immunostimulant developed by Japanese researchers. [Internet]. [updated 2015 Nov 3]. Available from: https://www.nutranews.org/en--immune-support--ahcc-powerful-immunostimulant-developed-by-japanese-researchers--125.
23The Power of Nature. AminoUp. AHCC® is a functional ingredient that modulates the body’s immune system. [Internet]. AminoUp; [updated, date not provided; cited 2019 Feb 13]. Available from: https://www.aminoup.co.jp/en/products/ahcc/. 27
24Smith JA, Mathew L, Gaikwad A, Rech B, Burney MN, Faro JP, et al. From bench to bedside: Evaluation of AHCC supplementation to modulate the host immunity to clear high-risk human papillomavirus infections. Front Oncol. 2019 Mar 20;9:173. doi: 10.3389/fonc.2019.00173.
25Ito T, Urushima H, Sakaue M, Yukawa S, Honda H, Hirai K, et al. Reduction of adverse effects by a mushroom product, active hexose correlated compound (AHCC) in patients with advanced cancer during chemotherapy - the significance of the levels of HHV-6 DNA in saliva as a surrogate biomarker during chemotherapy. Nutr Cancer. 2014;66(3):377-82. doi:10.1080/01635581.2014.884232.
26Zeuthen LH, Christensen HR, Frokiaer H. Lactic acid bacteria inducing a weak interleukin-12 and tumor necrosis factor alpha response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with gram-negative bacteria. Clin Vaccine Immunol. 2006 Mar;13(3):365-75. doi: 10.1128/CVI.13.3.365-375.2006.
27Costa DJ, Marteau P, Amouyal M, Poulsen LK, Hamelmann E, Cazaubiel M, et al. Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial (GA2LEN Study). Eur J Clin Nutr. 2014 May;68(5):602-7.
28Hatakka K, Martio J, Korpela M, Herranen M, Poussa T, Laasanen T, et al. Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis – a pilot study. Scan J Rheumatol. 2003;32:211-215.
29Gupta P, Andrew H, Kirschner BS, Guandalini S. Is Lactobacillus GG helpful in children with Crohn’s disease? Results of a preliminary, open-label study. Journal Paediatric Gastroenterology and Nutrition. 2000. 31:453-57.
30Zocco MA, dal Verme LZ, Cremonini F, Piscaglia AC, Nista EC, Candelli M, et al. Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Alimentary Pharmacology and Therapeutics. 2006;23:1567-1574.
31Powell M. The use of Ganoderma lucidum (Reishi) in the management of histamine-mediated allergic responses. Townsend Letter: The Examiner of Alternative Medicine. 2006 May 1(274):78-82.
32Chang H-M, But P P-H. Pharmacology and applications of Chinese materia medica. Vol 1. Singapore: World Scientific Publishing Co. Pte. Ltd; 2001. p. 598.
33Ishihara T, Okamoto I, Masaki N, Kohno K, Tanimoto T, Ikegami H, et al. [Inhibition of antigen-specific T helper type 2 responses by Perilla frutescens extract]. Arerugi. 1999 Apr;48(4):443-50.
34Saxena VS, Venkateshwarlu K, Nadig P, Barbhaiya HC, Bhatia N, Borkar DM, et al. Multicenter clinical trials on a novel polyherbal formulation in allergic rhinitis. Int J Clin Pharmacol Res. 2004;24(2-3):79-94.
35Vyjayanthi G, Subhashchandra S, Saxena V, Nadig P, Venkateshwarlu K, Serene A, et al. Randomized, double-blind, placebo-controlled trial of Aller-7® in patients with allergic rhinitis. Res Commun Pharmacol Toxicol. 2003;8(1):23-34.
36Amit A, Joshua AJ, Bagchi M, Bagchi D. Safety of a novel botanical extract formula for ameliorating allergic rhinitis. Part II. Toxicol Mech Methods. 2005;15(3):193-204.
37D'Souza P, Amit A, Saxena VS, Bagchi D, Bagchi M, Stohs SJ. Antioxidant properties of Aller-7®, a novel polyherbal formulation for allergic rhinitis. Drugs Exp Clin Res. 2004;30(3):99-109.
38Li Y, Yao J, Han C, Yang J, Chaudhry MT, Wang S, et al. Quercetin, inflammation and immunity. Nutrients. 2016 Mar 15;8(3):167.
39Chirumbolo S. The role of quercetin, flavonols and flavones in modulating inflammatory cell function. Inflamm Allergy Drug Targets. 2010 Sep;9(4):263-85.
40Thornhill SM, Kelly AM. Natural treatment of perennial allergic rhinitis. Altern Med Rev. 2000 Oct;5(5):448-54.
41Camacho-Barquero, Villegas I, Sánchez-Calvo JM, Talero E, Sánchez-Fidalgo S, Motilva V, et al. Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. Int Immunopharmacol. 2007;7(3):333-342.
42Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Altern Complement Med. 2003;9(1):161-8.
43Plummer SM, Holloway KA, Manson MM, Munks RJ, Kaptein A, Farrow S, et al. Inhibition of cyclo-oxygenase 2 expression incolon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene. 1999;18(44):6013-20.
44Takada Y, Ichikawa H, Badmaev V, Aggarwal BB. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression. J Immunol. 2006 Mar 1;176(5):3127-3140.
45Uchida S, Hirai K, Hatanaka J, Hanato J, Umegaki K, Yamada S. Antinociceptive effects of St John’s wort, harpogophytum procumbens extract and grape seed proanthocyanidins extract in mice. Biol Pharm Bull. 2008;31(2):240-245.
46Jamaican dogwood. In: Natural Medicines Comprehensive Database [database on the Internet]. Stockton (CA): Therapeutic Research Faculty; 1995-2018 [updated 2018 Apr 14; cited 2018 Sep 10]. Available from: http://www.naturaldatabase.com. Subscription required to view.
47Spite M, Clària J, Serhan CN. Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab. 2014 Jan 7;19(1):21-36. doi: 10.1016/j.cmet.2013.10.006.
48Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014 Jun 5;510(7503):92-101. doi: 10.1038/nature13479.
49Wessels I, Maywald M, Rink L. Zinc as a gatekeeper of immune function. Nutrients. 2017 Nov 25;9(12). pii: E1286. doi: 10.3390/nu9121286.
50Braun L, Cohen M. Herbs and natural supplements: an evidence-based guide. 4th ed. Vol 2. Sydney (AU): Elsevier/Churchill Livingstone; 2015. p. 1200-01.
51Baghurst K; Chair of the Working party (editor) Australian Government. Department of Health and Ageing, National Health and Research Medical Council. Zinc Nutritional Reference Values for Australia and New Zealand including Recommended Dietary Intakes. 2005.
52Maggini S, Beveridge S, Suter M. A combination of high-dose vitamin C plus zinc for the common cold. J Int Med Res. 2012;40(1):28-42. PMID: 22429343.
53Maggini S, Pierre A, Calder PC. Immune function and micronutrient requirements change over the life course. Nutrients. 2018 Oct 17;10(10). pii: E1531. doi: 10.3390/nu10101531.
54Fisher SA, Rahimzadeh M, Brierley C, Gration B, Doree C, Kimber CE, et al. The role of vitamin D in increasing circulating T regulatory cell numbers and modulating T regulatory cell phenotypes in patients with inflammatory disease or in healthy volunteers: A systematic review. PLoS One. 2019 Sep 24;14(9):e0222313. doi: 10.1371/journal.pone.0222313.
55Mocanu V, Oboroceanu T, Zugun-Eloae F. Current status in vitamin D and regulatory T cells--immunological implications. Rev Med Chir Soc Med Nat Iasi. 2013 Oct-Dec;117(4):965-73. PMID: 24502077.
56Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum. 2007;56(7):2143-9.
57Manzano-Alonso ML, Castellano-Tortajada G. Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy. World J Gastroenterol. 2011 Mar 28;17(12):1531-7. doi: 10.3748/wjg.v17.i12.